pirfenidone has been researched along with Ureteral Obstruction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y; Jiang, Z; Ma, L; Meng, W; Wang, J; Zhou, Y | 1 |
| Gu, C; Li, Z; Liu, X; Nie, Y; Wang, B; Wang, Q; Wen, J | 1 |
| Fukagawa, M; Hata, S; Kuroda, T; Kurokawa, K; Margolin, SB; Shimizu, T | 1 |
3 other study(ies) available for pirfenidone and Ureteral Obstruction
| Article | Year |
|---|---|
Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone.
Topics: Animals; Constriction, Pathologic; Iatrogenic Disease; Rabbits; Stents; Ureter; Ureteral Obstruction | 2022 |
Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Topics: Actins; Animals; Antigens, CD; Cadherins; Cell Line; Collagen Type I; Collagen Type III; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Fibrosis; Humans; JNK Mitogen-Activated Protein Kinases; Kidney Diseases; Kidney Tubules, Proximal; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridones; Rats, Sprague-Dawley; Renal Agents; S100 Calcium-Binding Protein A4; Transforming Growth Factor beta1; Ureteral Obstruction | 2017 |
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Collagen; Disease Models, Animal; Fibrosis; Gelatinases; Hydroxyproline; Inulin; Kidney Cortex; Kidney Function Tests; Ligation; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Pyridones; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Ribosomal, 18S; RNA, Ribosomal, 28S; Transforming Growth Factor beta; Ureter; Ureteral Obstruction | 1998 |